Zhejiang Leapmotor Technology Co. , Ltd. Class H has recently attracted fresh interest from several analysts, boosting its appeal to investors. A China Renaissance analyst kept a Buy recommendation and set a target price of HK$79, suggesting confidence in the company’s future prospects. Earlier this
Zhejiang Leapmotor Technology, a rising star in the electric vehicle (EV) industry, has caught the eye of analysts. Alexander Potter, a well-regarded expert, has recently given the company a thumbs-up. He believes the stock is a good buy and predicts it could reach HK$69. 00. This is notable because
Zhengsui Wan (ZSW) has been a go-to traditional Chinese medicine for treating Acute Lymphoblastic Leukemia (ALL) in many institutions. But how does it actually work? To find out, researchers turned to network pharmacology and molecular docking. They wanted to see if ZSW could fight ALL in lab settin
